Web references

1. Farmer P, Léandre F, Mukherjee JS, Claude MS, Nevil P, Smith , Fawzi MC, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001;358:404-9.
2. Weidle PJ, Malamba S, Mwebaze R, Sozi C, Rukundo G, Downing R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients’ response, survival, and drug resistance. Lancet 2002;360:34-40.
3. World Health Organization. Emergency scale-up of antiretroviral therapy in resource-limited settings: technical and operational recommendations to achieve 3 by 5. Geneva: WHO, 2003.
4. UN Integrated Regional Information Networks. Over 14 000 on subsidised aids drugs run out of medication. 3 Feb 2004. PlusNews.org/AIDSReport.ASP?ReportID=2986&selectRegion=West_Africa&Selectcountry=NIGERIA (accessed 2 Nov 2004).
5. UNAIDS. UNAIDS/WHO policy statement on HIV testing. Geneva: UNAIDS, 2004.
6. World Health Organisation. HIV/AIDS: confronting the epidemic. Resolution of the Executive Board of WHO, 105th session, Geneva, 28 January 2000.
7. UNAIDS. Stigma and discrimination fact sheet. Geneva: UNAIDS, 2003.
8. Sow K, Desclaux A. Living with HAART in Senegal. In: Desclaux A, Laniece I, Ndoye I, Taverne B, eds. The Senegalese Antiretroviral Drug Access Initiative. An Economic, Social, Behavioural and Biomedical Analysis. Vassel: ANRS, UNAIDS, WHO, 2004:147-156. www.ird.sn/activites/sida/resultats/publication.htm#2004 (accessed 2 Nov 2004)
9. Desclaux A. Stigmatisation and discrimination: what does a cultural approach have to offer? In: HIV/AIDS, stigma and discrimination: an anthropological approach. Paris: Division des politiques culturelles et du dialogue interculturel, UNESCO, 2003:1-10. (Studies and reports, special series No 20.)
10. Nyblade L, Pande R, Mathur S, MacQuarrie K, Kidd R, Banteyerga H, et al. Disentangling HIV and AIDS stigma in Ethiopia, Tanzania and Zambia. Washington, DC: International Center for Research on Women, 2003. Available from http://www.icrw.org/docs/stigmareport093003.pdf (Accessed 2 November 2004).
11. Leandre F, Claude MS, Nevil P, Farmer P, Mukherjee JS, Smith Fawzi MC, et al. Maximizing adherence and prevention of resistance through directly observed therapy: DOT-HAART. XIV International AIDS Conference, Barcelona, Spain, 7-12 July 2002. (Abstract MoPeB3246). Available from http://www.iasociety.org/abstract/show.asp?abstract_id=9461 (accessed 2 November 2004).
12. Walley JD, Khan MA, Newell JN, Khan MH. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001;357:664-9.
13. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998;352:1340-3.
14. Desclaux A, Sylla O, Lanièce I, Mbodj L, Ciss M, Diop K. The ISAARV Adherence-Support System. In: Desclaux A, Laniece I, Ndoye I, Taverne B, eds. The Senegalese Antiretroviral Drug Access Initiative. An Economic, Social, Behavioural and Biomedical Analysis. Vassel, ANRS, UNAIDS, WHO, 2004:109-118 www.ird.sn/activites/sida/resultats/publication.htm#2004 (accessed 2 Nov 2004)
15. World Health Organization. Mobilizing communities to achieve 3 by 5. Geneva: WHO, 2003.
16. Becker C, Dozon JP, Obbo C, Toure M, eds. Vivre et penser le sida en Afrique. Paris: Karthala, 1999.
17. Pialoux G. Affaire Therastim: l’espoir et les doutes. Transcriptase 2001;7:2-4.
18. Nguyen VK, Grennan T, Peschard K, Tan D, Tiendrébéogo I. Antiretroviral use in Ouagadougou, Burkina Faso. AIDS 2003;7(suppl 3): S109-11.
19. Desclaux A., Equity in access to AIDS treatment in Africa: pitfalls in achievements. In: Castro A, Singer M, eds. Unhealthy health policy: a critical anthropological examination.:Walnut Creek: AltaMira Press, 2003.
20. Peter Piot: what is HIV/AIDS leadership? The Correspondent 2004 Jul 12:11. http://hdnet-old.healthdev.org/aids2004/AIDS%20Newspaper%20Issue%2001.pdf (accessed 9 Sep 2004).